Healthy Resolutions names three partner pharmacies with full addresses and prices sermorelin at two separate strengths, and its page titled for its coverage publishes no coverage at all.
What Healthy Resolutions charges
NAD+: $400 — per vial; the page names no billing period and no supply length
Sermorelin: $375 — the 9 mg strength; the same line prints $450 for 15 mg and names no billing period
Sermorelin: $450 — the 15 mg strength; the same line prints $375 for 9 mg and names no billing period
Healthy Resolutions is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
A states page with no states on it
This seller publishes a page whose whole purpose is to say where it operates.
Rendered, that page carries a heading, a newsletter form and the site furniture, and no list of anywhere.
The only coverage statement on the entire site is a sentence in the sitewide footer naming four states.
A checker that opened the page named for the fact and found nothing would have recorded an absence that is not there.
Three pharmacies, named in full
The partner-pharmacy page names three facilities, each with a website, a street address and contact numbers.
One of the three is identified by its regulatory class rather than only by its trade name.
That is a checkable disclosure: a reader can look each facility up independently rather than take an accreditation on trust.
The company also publishes its own registered name in its copyright line, so there is an entity a reader can search.
Two strengths, priced separately
The growth-hormone product is priced at two strengths on a single line of the page.
Both are recorded as their own rows rather than averaged, ranged or reduced to one number.
The cellular-energy product is priced by the vial, with no billing period stated anywhere on its page.
Its own answers give an injection frequency, but a frequency is not a supply length and no monthly figure was derived from it.
A small footprint, stated
Four states are named, which makes most readers ineligible before anything else on this row matters.
Saying so is still better than leaving coverage to be discovered inside an intake after a reader has spent time on it.
No claim about lab work appears on either priced page, and the flag is false on an absence that was looked for.
The nonsense-path control on this host returns a not-found code and a plainly worded not-found document.
Who it's for
Readers in the four states this seller names.
Buyers who want the dispensing pharmacies named with addresses.
Shoppers who want two strengths of the same compound priced separately.
Anyone who wants a registered company name on the site they are buying from.
Who should look elsewhere
Readers outside its four states, which is most readers.
Buyers who need a billing period attached to a figure.
Shoppers who want a wider peptide menu than two compounds.
Anyone who expects lab work to be part of what they pay.
Strengths
Names three partner pharmacies with street addresses, phone numbers and one facility class
Prices two sermorelin strengths separately instead of publishing a single range
Publishes its registered company name rather than trading under a bare brand
States its coverage explicitly, however small, rather than leaving it to the intake
Trade-offs
Its "States We Cover" page publishes no states, so the only list is a footer sentence
Serves four states, so most readers are ineligible before anything else matters
Attaches no billing period to either priced compound
Makes no statement about lab work on either priced page
How we verified this
Read every page cited on this row as rendered text in a real browser, not as served HTML, because several sellers in this pass ship the figure in by script and serve a bare currency sign.
Fired a nonsense-path control at this host in the same run and judged it on the rendered document rather than on its status code or its byte count.
Joined every text node before scanning for a currency sign, so a figure split across nested elements could not read as an absence.
Clicked every collapsed accordion on the pages read, because pharmacy names, state answers and lab conditions hid inside them on most sellers checked this pass.
Read each figure inside its own card or panel rather than by nearness to a compound name, on pages that price weight-loss lines beside peptide lines.
Recorded the seller's own published figure and never divided a multi-month total into a monthly one.
Screened this seller in the live federal warning-letter record by entity and by brand, with a known-good positive control and a nonsense negative control fired in the same run.
Read the company column of every returned record rather than accepting a full-text match, and attached no letter unless the letter itself named this seller's own domain.
Opened the page named for this seller's coverage, found no list on it, and then found the only list in the sitewide footer.
Split the one line that carried two strengths into two separate records rather than averaging or ranging them.
Treated the stated injection frequency as a frequency and did not turn it into a supply length or a monthly figure.
A provider to compare Healthy Resolutions against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.